InVitro International (IVRO)
USD 0.1
(9.67%)
USD 0.1
(9.67%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 163.13 Thousand USD | 3.57% |
| 2022 | 157.51 Thousand USD | 12.21% |
| 2021 | 140.37 Thousand USD | -15.26% |
| 2020 | 165.65 Thousand USD | 7.41% |
| 2019 | 154.21 Thousand USD | 14.98% |
| 2018 | 134.12 Thousand USD | 4.58% |
| 2017 | 128.25 Thousand USD | -1.91% |
| 2016 | 130.74 Thousand USD | -7.08% |
| 2015 | 140.71 Thousand USD | 0.0% |
| 1996 | 400 Thousand USD | 100.0% |
| 1995 | 200 Thousand USD | -33.33% |
| 1994 | 300 Thousand USD | -40.0% |
| 1993 | 500 Thousand USD | 0.0% |
| 1992 | 500 Thousand USD | -16.67% |
| 1991 | 600 Thousand USD | -14.29% |
| 1990 | 700 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 184.33 Thousand USD | 13.0% |
| 2024 Q3 | 188.82 Thousand USD | -1.58% |
| 2024 Q2 | 191.84 Thousand USD | 4.07% |
| 2023 Q2 | 152.69 Thousand USD | 4.35% |
| 2023 FY | 163.13 Thousand USD | 3.57% |
| 2023 Q1 | 146.33 Thousand USD | -7.1% |
| 2023 Q4 | 163.13 Thousand USD | 3.28% |
| 2023 Q3 | 157.95 Thousand USD | 3.44% |
| 2022 Q2 | 178.49 Thousand USD | 0.11% |
| 2022 FY | 157.51 Thousand USD | 12.21% |
| 2022 Q4 | 157.51 Thousand USD | -10.14% |
| 2022 Q1 | 178.3 Thousand USD | 27.02% |
| 2022 Q3 | 175.3 Thousand USD | -1.79% |
| 2021 Q2 | 150.86 Thousand USD | 0.0% |
| 2021 FY | 140.37 Thousand USD | -15.26% |
| 2021 Q4 | 140.37 Thousand USD | -8.11% |
| 2021 Q3 | 152.77 Thousand USD | 1.27% |
| 2020 FY | 165.65 Thousand USD | 7.41% |
| 2019 FY | 154.21 Thousand USD | 14.98% |
| 2018 FY | 134.12 Thousand USD | 4.58% |
| 2017 FY | 128.25 Thousand USD | -1.91% |
| 2016 FY | 130.74 Thousand USD | -7.08% |
| 2015 FY | 140.71 Thousand USD | 0.0% |
| 1997 Q3 | 486 Thousand USD | -3.38% |
| 1997 Q2 | 503 Thousand USD | 0.0% |
| 1996 Q4 | 400 Thousand USD | 33.33% |
| 1996 FY | 400 Thousand USD | 100.0% |
| 1996 Q3 | 300 Thousand USD | 50.0% |
| 1996 Q1 | 200 Thousand USD | 0.0% |
| 1996 Q2 | 200 Thousand USD | 0.0% |
| 1995 Q4 | 200 Thousand USD | 0.0% |
| 1995 FY | 200 Thousand USD | -33.33% |
| 1994 Q3 | 400 Thousand USD | -20.0% |
| 1994 FY | 300 Thousand USD | -40.0% |
| 1994 Q4 | 300 Thousand USD | -25.0% |
| 1994 Q2 | 500 Thousand USD | 0.0% |
| 1994 Q1 | 500 Thousand USD | 0.0% |
| 1993 Q4 | 500 Thousand USD | 0.0% |
| 1993 Q2 | 400 Thousand USD | -20.0% |
| 1993 Q1 | 500 Thousand USD | 0.0% |
| 1993 Q3 | 500 Thousand USD | 25.0% |
| 1993 FY | 500 Thousand USD | 0.0% |
| 1992 Q2 | 600 Thousand USD | 0.0% |
| 1992 FY | 500 Thousand USD | -16.67% |
| 1992 Q3 | 500 Thousand USD | -16.67% |
| 1992 Q4 | 500 Thousand USD | 0.0% |
| 1991 Q3 | 700 Thousand USD | 0.0% |
| 1991 Q2 | 700 Thousand USD | 0.0% |
| 1991 Q4 | 600 Thousand USD | -14.29% |
| 1991 FY | 600 Thousand USD | -14.29% |
| 1990 FY | 700 Thousand USD | 0.0% |
| 1990 Q2 | 200 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Bio Medica Corporation | 379 Thousand USD | 56.956% |
| Arrayit Corporation | 464.19 Thousand USD | 64.856% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 757 Thousand USD | 78.45% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | -2385.00 USD | 6940.042% |
| DermTech, Inc. | 1 Million USD | 83.751% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | 95.055% |
| HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | 82.06% |
| iMD Companies, Inc. | 38.31 Thousand USD | -325.762% |
| IDenta Corp. | 442.28 Thousand USD | 63.115% |
| Interpace Biosciences, Inc. | 1.22 Million USD | 86.705% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | 784 Thousand USD | 79.192% |
| Many Bright Ideas Technologies Inc. | -375.00 USD | 43602.667% |
| Medical Imaging Corp. | - USD | -Infinity% |
| NovelStem International Corp. | - USD | -Infinity% |
| Optigenex Inc. | 468.77 Thousand USD | 65.2% |
| PharmChem, Inc. | 391.93 Thousand USD | 58.377% |
| Proteome Sciences plc | 1.06 Million USD | 84.689% |
| Response Genetics, Inc | 133 Thousand USD | -22.658% |
| Rennova Health, Inc. | 242.64 Thousand USD | 32.768% |
| RushNet, Inc. | - USD | -Infinity% |
| ScreenPro Security Inc. | 73.89 Thousand USD | -120.76% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 95.62 Thousand USD | -70.606% |
| Todos Medical Ltd. | 1.02 Million USD | 84.022% |